| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-11-01 | Future report Set alerts | |
| Q2 2022 | 2022-08-05 | 0.64 | 0.64 |
| Q1 2022 | 2022-05-05 | 0.73 | 0.73 |
| Q4 2021 | 2022-02-09 | 0.62 | 0.62 |
| Q3 2021 | 2021-11-03 | 0.66 | 0.66 |
| Q2 2021 | 2021-08-04 | 0.72 | 0.72 |
| Q1 2021 | 2021-05-05 | 0.66 | 0.66 |
| Q4 2020 | 2021-02-10 | 0.61 | 0.61 |
| Q3 2020 | 2020-11-04 | 0.00 | 0.00 |
| Q2 2020 | 2020-08-05 | 0.52 | 0.25 |
| 2016-06-28 | Downgrade | JPMorgan Chase & Co. | Overweight to Neutral | $27.00 |
| 2016-06-26 | Reiterated Rating | Wedbush | Buy | |
| 2016-06-24 | Boost Price Target | Wedbush | Outperform | $27.00 to $29.00 |
| 2016-06-13 | Initiated Coverage | Raymond James | Outperform | $30.00 |
| 2016-06-13 | Initiated Coverage | Raymond James Financial Inc. | Outperform | $30.00 |
| 2016-05-11 | Initiated Coverage | FBR & Co. | Outperform | $32.00 |
| 2016-05-11 | Initiated Coverage | FBR & Co | Outperform | $32.00 |
| 2016-04-30 | Reiterated Rating | Wedbush | Buy | |
| 2016-04-29 | Lower Price Target | Wedbush | Outperform | $28.00 to $27.00 |
| 2016-04-26 | Reiterated Rating | Morgan Stanley | Hold | |
| 2016-04-25 | Reiterated Rating | Oppenheimer | Buy | |
| 2016-04-25 | Reiterated Rating | Oppenheimer Holdings Inc. | Buy | |
| 2016-04-01 | Downgrade | William Blair | Outperform to Market Perform | |
| 2016-02-25 | Upgrade | Goldman Sachs | Buy to Conviction-Buy | $29.00 |
| 2016-02-25 | Upgrade | Goldman Sachs Group Inc. | Buy to Conviction-Buy | $29.00 |
| 2016-02-11 | Reiterated Rating | Oppenheimer | Outperform | $32.00 |
| 2016-02-11 | Reiterated Rating | Wedbush | Outperform | $28.00 |
| 2016-02-10 | Upgrade | Needham & Company LLC | Hold to Buy | $24.00 |
| 2016-02-10 | Upgrade | Oppenheimer | Buy | |
| 2016-02-10 | Lower Price Target | JPMorgan Chase & Co. | Overweight | $25.00 to $24.00 |
| 2016-02-02 | Reiterated Rating | Oppenheimer | Outperform | $32.00 |
| 2016-02-01 | Reiterated Rating | MKM Partners | Hold | $20.00 to $21.00 |
| 2015-12-27 | Reiterated Rating | Piper Jaffray | Buy | |
| 2015-12-27 | Reiterated Rating | Piper Jaffray Cos. | Buy | |
| 2015-12-21 | Reiterated Rating | Piper Jaffray | Buy | $22.00 to $26.00 |
| 2015-12-09 | Initiated Coverage | Oppenheimer | Outperform to Outperform | $32.00 |
| 2015-12-01 | Initiated Coverage | Wedbush | Outperform | $28.00 |
| 2015-10-31 | Reiterated Rating | Piper Jaffray | Buy | |
| 2015-10-30 | Upgrade | Robert W. Baird | Neutral to Outperform | $19.00 to $24.00 |
| 2015-10-05 | Lower Price Target | Robert W. Baird | Neutral | $25.00 to $19.00 |
| 2015-09-25 | Lower Price Target | JPMorgan Chase & Co. | Overweight | $24.00 to $22.00 |
| 2015-09-21 | Initiated Coverage | Morgan Stanley | Equal to Equal Weight | $20.00 |
| 2015-08-24 | Lower Price Target | JPMorgan Chase & Co. | Overweight | $25.00 to $24.00 |
| 2015-08-05 | Reiterated Rating | Piper Jaffray | Overweight | $27.00 to $25.00 |
| 2015-08-05 | Lower Price Target | Craig Hallum | Hold | $24.00 to $20.00 |
| 2015-08-05 | Reiterated Rating | MKM Partners | Buy to Neutral | $31.00 to $21.00 |
| 2015-06-12 | Reiterated Rating | Piper Jaffray | Overweight | $30.00 to $28.00 |
| 2015-03-19 | Initiated Coverage | Goldman Sachs | Neutral | $29.00 |
| 2015-02-11 | Lower Price Target | JPMorgan Chase & Co. | Overweight | $32.00 to $31.00 |
| 2015-02-11 | Lower Price Target | Dougherty & Co | Buy | $32.00 to $28.00 |
| 2015-02-09 | Reiterated Rating | William Blair | Buy | |
| 2015-01-28 | Initiated Coverage | Boenning Scattergood | Neutral | |
| 2015-01-07 | Downgrade | Robert W. Baird | Outperform to Neutral | $33.00 to $29.00 |
| 2014-10-31 | Lower Price Target | MKM Partners | Buy | $39.00 to $32.00 |
| 2014-08-06 | Reiterated Rating | JPMorgan Chase & Co. | Overweight | $41.00 to $39.00 |
| 2014-08-06 | Lower Price Target | MKM Partners | Buy | $40.00 to $39.00 |
| 2014-05-12 | Upgrade | Ned Davis Research | Sell to Neutral | |
| 2014-05-05 | Boost Price Target | MKM Partners | Buy | $38.00 to $41.00 |
| 2014-03-05 | Upgrade | JPMorgan Chase & Co. | Neutral to Overweight | $36.00 to $43.00 |
| 2014-01-06 | Downgrade | Craig Hallum | Buy to Hold | |
| 2013-12-16 | Reiterated Rating | Janney Montgomery Scott | Fair Value | $35.00 to $40.00 |
| 2013-11-12 | Initiated Coverage | Pacific Crest | Buy to Hold | $37.00 to $60.00 |
| 2013-11-12 | Initiated Coverage | MKM Partners | Buy | $37.00 |
| 2013-10-28 | Downgrade | Needham & Company LLC | Buy to Hold | |
| 2013-09-05 | Initiated | Robert W. Baird | Outperform | $36 |
| 2011-04-29 | Reiterated | Oppenheimer | Outperform | $53 to $56 |
| 2010-12-22 | Reiterated | Dougherty & Company | Buy | $43 to $45 |
| 2010-04-30 | Reiterated | Oppenheimer | Outperform | $29 to $34 |
| 2016-06-28 | Downgrade | JPMorgan Chase & Co. | Overweight to Neutral | $27.00 |
| 2016-06-26 | Reiterated Rating | Wedbush | Buy | |
| 2016-06-24 | Boost Price Target | Wedbush | Outperform | $27.00 to $29.00 |
| 2016-06-13 | Initiated Coverage | Raymond James | Outperform | $30.00 |
| 2016-06-13 | Initiated Coverage | Raymond James Financial Inc. | Outperform | $30.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In TRMB 418 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| Vanguard Group, Inc | 27.84M |
| BlackRock Inc. | 19.38M |
| Capital International Investors | 15.83M |
| BlackRock Fund Advisors | 9.98M |
| STATE STREET CORP | 9.96M |
| Select Equity Group, L.P. | 8.06M |
| BlackRock Institutional Trust Company, N.A. | 7.79M |
| PRIMECAP MANAGEMENT CO/CA/ | 5.55M |
| GEODE CAPITAL MANAGEMENT, LLC | 5.10M |
| Impax Asset Management LTD | 4.63M |
| Sumitomo Mitsui Trust Holdings, Inc. | 4.49M |
| PICTET ASSET MANAGEMENT LTD | 4.29M |
| KING LUTHER CAPITAL MANAGEMENT CORP | 4.08M |
| GENERATION INVESTMENT MANAGEMENT LLP | 3.41M |
| NORDEA INVESTMENT MANAGEMENT AB | 3.26M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| BERGLUND STEVEN W President and CEO | 0.14% (375114) | BDC / TRMB / |
| HART WILLIAM | 0.07% (183804) | TRMB / |
| GOODRICH JOHN B | 0.03% (67384) | TRMB / TSRA / |
| Gibson Chris Vice President | 0.02% (55942) | TRMB / |
| KIRKLAND JAMES A Vice President | 0.02% (46763) | TRMB / |
| Kliem Jurgen Vice President | 0.02% (40646) | TRMB / |
| FOSBURGH BRYN Vice President | 0.01% (38194) | TRMB / |
| EKHOLM BORJE | 0.01% (33670) | NDAQ / TRMB / |
| PEEK MARK S | 0.01% (33074) | TRMB / WDAY / |
| Janow Merit E | 0.01% (30356) | MA / TRMB / |
| JOHANSSON ULF J | 0.01% (30356) | TRMB / |
| Shepard Julie A Vice President | 0.01% (25448) | TRMB / |
| Nersesian Ronald S. | 0.01% (24506) | A / TRMB / |
| SANKPAL SACHIN SVP & Sector Head | 0.01% (21148) | TRMB / |
| Lloyd Meaghan | 0.01% (19403) | TRMB / |
| Gabriel Kaigham | 0.01% (18356) | TRMB / |
| PAINTER ROBERT G CFO | 0.01% (15450) | TRMB / |
| VANDE STEEG NICKOLAS | 0.01% (14653) | TRMB / WAB / |